"Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]." Clinical Epidemiology, , pp. 763–764
Acknowledgments
This work was performed as part of the Clinical Academic Group (ACUTE-CAG) for Recovery Capacity funded by the Greater Copenhagen Health Science Partners (GCHSP).
Disclosure
The authors declare no conflicts of interest in relation to this communication.
Additional information
Funding
Morten Baltzer Houlind was supported by a postdoctoral fellowship from The Capital Region’s Research Foundation for Health Research, Denmark (grant-A6882).